Notably, PRTN3 exhibited a consistent upregulation pattern across both the discovery and validation cohorts for both IDD and DM, suggesting its potential as a key biomarker with significant biological relevance in both diseases. The gene discussed is PRTN3; the disease is diabetes mellitus.